2022 ICD-10-CM Code D03.3

Melanoma in situ of other and unspecified parts of face

Version 2021

Not Valid for Submission

ICD-10:D03.3
Short Description:Melanoma in situ of other and unspecified parts of face
Long Description:Melanoma in situ of other and unspecified parts of face

Code Classification

D03.3 is a non-specific and non-billable diagnosis code code, consider using a code with a higher level of specificity for a diagnosis of melanoma in situ of other and unspecified parts of face. The code is not specific and is NOT valid for the year 2022 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.

Unspecified diagnosis codes like D03.3 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.

Specific Coding for Melanoma in situ of other and unspecified parts of face

Non-specific codes like D03.3 require more digits to indicate the appropriate level of specificity. Consider using any of the following ICD-10 codes with a higher level of specificity when coding for melanoma in situ of other and unspecified parts of face:

  • BILLABLE CODE - Use D03.30 for Melanoma in situ of unspecified part of face
  • BILLABLE CODE - Use D03.39 for Melanoma in situ of other parts of face

Information for Patients


Melanoma

Melanoma is the most serious type of skin cancer. Often the first sign of melanoma is a change in the size, shape, color, or feel of a mole. Most melanomas have a black or black-blue area. Melanoma may also appear as a new mole. It may be black, abnormal, or "ugly looking."

Thinking of "ABCDE" can help you remember what to watch for:

Surgery is the first treatment of all stages of melanoma. Other treatments include chemotherapy and radiation, biologic, and targeted therapies. Biologic therapy boosts your body's own ability to fight cancer. Targeted therapy uses substances that attack cancer cells without harming normal cells.

NIH: National Cancer Institute


[Learn More in MedlinePlus]

Melanoma Summary Learn about melanoma risk factors, symptoms, tests to diagnose, factors affecting prognosis, staging, and treatment.
[Learn More in MedlinePlus]

Code History

  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)